Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agop Y. Bedikian, MD
M.D. Anderson Cancer Center
Principal Investigator - Andres Forero, M.D.
University of Alabama at Birmingham
Principal Investigator - Antoni Ribas, MD
University of California, Los Angeles
Principal Investigator - Colin P. Curran, M.D.
Palmetto Hematology Oncology, P.C.
Principal Investigator - John Kirkwood, M.D.
University of Pittsburgh
Principal Investigator - Lee Cranmer, M.D.
University of Arizona
Principal Investigator - Steven J. O'Day, M.D.
Cancer Institute Medical Group, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham-Comprehensive Cancer Ctr.
Birmingham, Alabama, United States
- Arizona Cancer Center
Tucson, Arizona, United States
- Ucla School of Medicine
Los Angeles, California, United States
- Cancer Institute Medical Group, Inc.
Santa Monica, California, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Palmetto Hematology Oncology, P.C.
Spartanburg, South Carolina, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2004
- Primary completion
- —
- Completion
- 31 Mar 2006
- Last update posted
- 5 Aug 2008
- Registered enrollment
- 40
- Registry id
- NCT00099970
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.